Elanco (ELAN) Animal Health announced it has received Emergency Use Authorization from the U.S. FDA for Credelio to treat New World screwworm infestations in dogs. This is the first EUA ever granted by the Agency for NWS in dogs. Confirmed cases of NWS have been detected less than 70 miles south of the U.S.-Mexico border. This Emergency Use Authorization allows veterinarians and pet owners to have a ready-now treatment option if the fly enters the U.S.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Elanco’s Credelio receives FDA Emergency Use Authorization
- Elanco price target raised to $25 from $19 at UBS
- 3 Stocks That Technical Analysis Flags as Must-Buys Today
- Elanco upgraded to Overweight from Neutral at JPMorgan
- Elanco Animal Health: Promising Growth Driven by Innovation and Market Dynamics